Cargando…
Ginkgolides protect against amyloid-β(1–42)-mediated synapse damage in vitro
BACKGROUND: The early stages of Alzheimer's disease (AD) are closely associated with the production of the Aβ(1–42 )peptide, loss of synapses and gradual cognitive decline. Since some epidemiological studies showed that EGb 761, an extract from the leaves of the Ginkgo biloba tree, had a benefi...
Autores principales: | Bate, Clive, Tayebi, Mourad, Williams, Alun |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2254622/ https://www.ncbi.nlm.nih.gov/pubmed/18179689 http://dx.doi.org/10.1186/1750-1326-3-1 |
Ejemplares similares
-
Ginkgolide B inhibits the neurotoxicity of prions or amyloid-β(1-42)
por: Bate, Clive, et al.
Publicado: (2004) -
α-synuclein induced synapse damage is enhanced by amyloid-β(1-42)
por: Bate, Clive, et al.
Publicado: (2010) -
Phospholipase A(2 )inhibitors protect against prion and Aβ mediated synapse degeneration
por: Bate, Clive, et al.
Publicado: (2010) -
cAMP-Inhibits Cytoplasmic Phospholipase A(2) and Protects Neurons against Amyloid-β-Induced Synapse Damage
por: Bate, Clive, et al.
Publicado: (2015) -
Breaking the Cycle, Cholesterol Cycling, and Synapse Damage in Response to Amyloid-β
por: Bate, Clive
Publicado: (2017)